Tele-Physiotherapy Tool for Managing Musculoskeletal Pain in Visually Impaired Individuals
Development of a Tele-Physiotherapy Tool for the Early Management of Muskuloskeletal Pain in People With Visual Impairement (TeleEDxPhysio)
This study is testing a new online physiotherapy tool to help visually impaired people manage their chronic low back pain and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 128 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Escuela Universitaria de Fisioterapia de la Once Academic / other |
| Locations | 2 sites (Zaragoza, Aragón and 1 other locations) |
| Trial ID | NCT05478200 on ClinicalTrials.gov |
What this trial studies
This study focuses on developing a tele-physiotherapy tool aimed at the early management of chronic non-specific low back pain (CNSLBP) in individuals with visual impairment. It utilizes therapeutic exercise and manual therapy delivered through tele-assistance platforms, which are currently not accessible for visually impaired patients. The approach aims to enhance physical activity levels and overall quality of life by providing tailored exercise programs that accommodate the unique needs of this population. The study will assess the effectiveness of these interventions over a specified period.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals with chronic non-specific low back pain lasting 12 weeks or more, particularly those who experience pain associated with specific movements and positions.
Not a fit: Patients with acute low back pain lasting less than 12 weeks or those with serious underlying medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could significantly improve the physical activity and quality of life for visually impaired individuals suffering from chronic low back pain.
How similar studies have performed: While tele-assistance platforms have shown promise in other populations, this specific approach for visually impaired individuals with CNSLBP is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Suffer CNSLBP of 12 weeks or more evolution, whose pain location is mainly from T12 to the gluteal folds, with or without referred pain to the lower extremities. * Pain that is provoked and relieved by different positions, movements and activities. In other words, mechanical behaviour. * Low back pain whose movement behaviours have a clear association with their pain disorder. Exclusion Criteria: * Presence of 1 or more red flags (any sign or symptom that warns of the possible presence of a serious medical condition that may cause irreversible disability or death if not treated appropriately). * Presence of non-specific low back pain of less than 12 weeks' duration. * Diagnosis of specific low back pain by a physician (radicular pain, herniated disc, spondylolisthesis, stenosis, etc.), any lower limb or lumbar spine surgery within the last 3 months, pregnancy, pain without clear mechanical behaviour, active rheumatological disease, progressive neurological disease, severe cardiac or other systemic medical condition, malignant disease, acute osteoarticular trauma, fractures, infections or acute vascular problems.
Where this trial is running
Zaragoza, Aragón and 1 other locations
- Universidad de Zaragoza (Clínica Valdespartera y CS Seminario) — Zaragoza, Aragón, Spain (Recruiting)
- Escuela Unviersitaria de Fisioterapia de la ONCE — Madrid, Spain (Recruiting)
Study contacts
- Principal investigator: João Sousa, MSc — Escuela Universitaria de Fisioterapia de la Once
- Study coordinator: João Mota, MSc
- Email: jmde@once.es
- Phone: (+34) 91 589 45 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.